Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVO... by Jessica Ailani, J. Scott Andrews, Mallikarjuna Rettiganti, Robert A. Nicholson

Get full text

Response to van Dyck, O'Dell, & Mecca letter to the editor regarding Andrews et al. (2019) by J. Scott Andrews, Urvi Desai, Noam Y. Kirson, Brandy R. Matthews

Get full text

Disease severity at the time of initial cognitive assessment is related to prior health‐care resource use burden by Urvi Desai, Noam Y. Kirson, Yao Lu, Valerie Bruemmer, J. Scott Andrews

Get full text

Trends in health service use and potentially avoidable hospitalizations before Alzheimer's disease diagnosis: A matched, retrospective study of US Medicare beneficiaries by Urvi Desai, Noam Y. Kirson, Wenyu Ye, Nori R. Mehta, Jody Wen, J. Scott Andrews

Get full text

Efficacy of galcanezumab in patients with episodic cluster headaches and a history of preventive treatment failure by Brian Plato, J Scott Andrews, Mallikarjuna Rettiganti, Antje Tockhorn-Heidenreich, Jennifer Bardos, Richard Wenzel, Dulanji Kuruppu, Anna Ambrosini

Get full text